Voir la présentation (cancer en France)

CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
ARIIS EFS INERIS INSTITUT CURIE INSTITUT MINES-TELECOM UNICANCERIRBA IRSNCIRAD FONDATION MERIEUX
1
ITMO Cancer
Cancer
organisation in
France
CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
ARIIS EFS INERIS INSTITUT CURIE INSTITUT MINES-TELECOM UNICANCERIRBA IRSNCIRAD FONDATION MERIEUX
AVIESAN: National Alliance
for life and health sciences
INCa: National Cancer
Institute

CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
ARIIS EFS INERIS INSTITUT CURIE INSTITUT MINES-TELECOM UNICANCERIRBA IRSNCIRAD FONDATION MERIEUX
Overview of Cancer research in France
800 research teams- 6000 researchers, MDs,
Technicians and administrative staff
85 universities, 26 medical schools- 10
Institutions of which Inserm-CNRS …
•One single desk: AVIESAN Cancer
•National Cancer Institute –INCa: project funding
A common strategy and a national cancer
plan (2009-2014), dedicated budget : 2,5
billion euros including 500 millions for
research
2

CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
ARIIS EFS INERIS INSTITUT CURIE INSTITUT MINES-TELECOM UNICANCERIRBA IRSNCIRAD FONDATION MERIEUX
Accelerating translation of innovation to
patients
Research Infrastructures Tools to improve research
•
Comprehensive Cancer research
centres –8 SIRIC
•
Early phase clinical trial centres -
16 CLIP2
•
Molecular Genetics Centres
•
Clinical trial Registry
•
Clinical research
•
Cohorts
•
Data processing centres
•
Cooperative groups
•
Clinical-biological Databases
3

CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
ARIIS EFS INERIS INSTITUT CURIE INSTITUT MINES-TELECOM UNICANCERIRBA IRSNCIRAD FONDATION MERIEUX
833 Aviesan Cancer teams
4
10-30 Teams
30-80 teams
80-350 teams
1-10 teams
336 53
5
8
2
6
1
75
61
27
38
49
46
46
3
20
1
16
1
1
12
10
3
3
21
25
212
50
57
213
2
Paris area

CEA CHRU CNRS CPU INRA INRIA INSERM INSTITUT PASTEUR IRD
ARIIS EFS INERIS INSTITUT CURIE INSTITUT MINES-TELECOM UNICANCERIRBA IRSNCIRAD FONDATION MERIEUX
10 actions for the next 5 years
5
Genomics and personalized medicine
Medication, molecular pharmacology and
biomarkers
Metabolism, infection, inflammation,
immunology and cancer
Human and social sciences and
epidemiology
Epidemiology, epigenetics and environment
1
2
3
4
5